MONITORING OF PATIENTS WITH ULCERATIVE COLITIS IN PRIMARY CARE SETTINGS AND THE CLINICAL AND PROGNOSTIC SIGNIFICANCE OF CRP AND ESR IN THEM

Article Sidebar

PDF (Uzbek (Latin))
Published: 2025-08-05
DOI: https://doi.org/10.66073/researchfocus.v4i7.1734
Keywords:
Nonspecific ulcerative colitis, biomarker, C-reactive protein, erythrocyte sedimentation rate, prognosis, autoimmune

Main Article Content

Maxkamov Mansurjon Maxmudjonovich
Head of the Gastroenterology Department, Namangan City Hospital No. 1
Zakirova Umida Irkinovna
Doctor of Medical Sciences, Associate Professor, Department of “Children’s Diseases and Family Medicine”, Tashkent Medical Academy

Abstract

Nonspecific ulcerative colitis (NUC) is a disease that proceeds with autoimmune and inflammatory processes and continues with alternating remissions and relapses. The course of the disease, its prognosis and the effectiveness of treatment differ in every patient, and treatment has to be carried out over many years. This article analyses the significance of the erythrocyte sedimentation rate and of C-reactive protein (CRP) as biomarkers of inflammation, and their role in diagnosis, in assessing disease activity and in monitoring the effectiveness of treatment.

Article Details

Issue

Vol. 4 No. 7 (2025): Research Focus International Scientific Journal. Volume 4, Issue 7 (2025)

Section

14.00.00 – Medical sciences
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

MONITORING OF PATIENTS WITH ULCERATIVE COLITIS IN PRIMARY CARE SETTINGS AND THE CLINICAL AND PROGNOSTIC SIGNIFICANCE OF CRP AND ESR IN THEM. (2025). Research Focus International Scientific Journal, 4(7), 75-78. https://doi.org/10.66073/researchfocus.v4i7.1734

References

Pepys, M. B., & Hirschfield, G. M. (2003). C-reactive protein: A critical update. The Journal of Clinical Investigation, 111(12), 1805–1812. https://doi.org/10.1172/JCI18921

Vermeire, S., Van Assche, G., & Rutgeerts, P. (2004). C-reactive protein as a marker for inflammatory bowel disease. Inflammatory Bowel Diseases, 10(5), 661–665. https://doi.org/10.1097/00054725-200409000-00025

Danese, S., & Fiocchi, C. (2011). Ulcerative colitis. New England Journal of Medicine, 365(18), 1713–1725. https://doi.org/10.1056/NEJMra1102942

Sands, B. E. (2003). Biomarkers of inflammation in inflammatory bowel disease. Gastroenterology, 124(2), 521–524. https://doi.org/10.1053/gast.2003.50066

reddit.com + 4pubmed.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov

Henriksen, M., Jahnsen, J., Lygren, I., Sauar, J., Schulz, T., Stray, N., ... & Vatn, M. H. (2008). C-reactive protein: A predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Gut, 57(11), 1518–1523. https://doi.org/10.1136/gut.2007.146399